| __timestamp | Bristol-Myers Squibb Company | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 5699000000 | 9079000 |
| Thursday, January 1, 2015 | 5001000000 | 20309000 |
| Friday, January 1, 2016 | 5002000000 | 16945000 |
| Sunday, January 1, 2017 | 4849000000 | 20559000 |
| Monday, January 1, 2018 | 4551000000 | 29641000 |
| Tuesday, January 1, 2019 | 4871000000 | 88258000 |
| Wednesday, January 1, 2020 | 7661000000 | 162170000 |
| Friday, January 1, 2021 | 7690000000 | 167218000 |
| Saturday, January 1, 2022 | 7814000000 | 239528000 |
| Sunday, January 1, 2023 | 7772000000 | 94252000 |
| Monday, January 1, 2024 | 8414000000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical industry, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Bristol-Myers Squibb Company, a titan in the field, has consistently demonstrated robust SG&A management over the past decade. From 2014 to 2023, their SG&A expenses have shown a steady increase, peaking in 2022 with a 37% rise from 2014. In contrast, Galapagos NV, a smaller player, has seen a more volatile trajectory. Their SG&A expenses surged by over 2500% from 2014 to 2022, reflecting their aggressive expansion strategy. This comparison highlights the strategic differences between established giants and emerging innovators. As Bristol-Myers Squibb focuses on maintaining efficiency, Galapagos NV invests heavily in growth, each navigating the complex pharmaceutical market in their unique way.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Bristol-Myers Squibb Company
Breaking Down SG&A Expenses: Johnson & Johnson vs Galapagos NV
Who Optimizes SG&A Costs Better? Amgen Inc. or Galapagos NV
Bristol-Myers Squibb Company or Zoetis Inc.: Who Manages SG&A Costs Better?
Bristol-Myers Squibb Company and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Galapagos NV
Rhythm Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing MorphoSys AG and Galapagos NV
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Galapagos NV
Breaking Down SG&A Expenses: Mesoblast Limited vs Galapagos NV
Cost Management Insights: SG&A Expenses for Dynavax Technologies Corporation and Galapagos NV